Standard Biotools | FLDM - Operating Profit


Standard Biotools reported $-9.42M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Agilent USD 399M 46M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Bruker USD 69.6M 59.4M Jun/2026
Danaher USD 1.13B 217M Jun/2026
Illumina USD 260M 21M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Nikon Corporation JPY -997M 7.82B Jun/2026
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Revvity USD 126.14M 43.36M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sony JPY 474.49B 245.18B Jun/2026
Standard Biotools USD -9.42M 12.51M Mar/2026
Thermo Fisher Scientific USD 2.18B 273M Jun/2026
Waters USD -86M 234M Jun/2026